Search results
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 3 days agoModerna representatives told news outlets that the company aspires to have the new shot approved by...
COVID shots should target JN.1 variant in 2024-25 campaign, US FDA says
Reuters· 6 days agoThe U.S. Food and Drug Administration on Friday advised COVID-19vaccine manufacturers that new shots...
FDA tells Covid-19 vaccine makers to update shot to target current virus variant
WKBT La Crosse· 6 days agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 3 days agoAn experimental two-in-one vaccine triggered strong immune responses against both the flu and SARS-CoV-2, the virus behind COVID-19, in an advanced clinical trial that included ...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
WKBT La Crosse· 6 days agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency tell vaccine manufacturers to update the Covid-19 shots for the fall.
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 2 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CBS 58 Milwaukee· 6 days agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency tell vaccine manufacturers to update the Covid-19 shots for the fall.
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga· 6 days agoThe submission is based on FDA guidance, which advised that COVID-19 vaccines should be updated to a...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 6 days agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA TODAY via Yahoo News· 5 days agoDuring the Vaccines and Related Biological Products Advisory Committee, health experts from vaccine manufacturers Pfizer, Moderna and Novavax< ...